Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(9 sites)

France

Ch Perrens, Bordeaux, France

CHU Bicêtre, Le Kremlin-Bicêtre

Hospices Civils de Lyon, Lyon

CAPPA Jacques PREVERT, Nantes

CHU Nîmes, Nîmes

CH Sainte-Anne, Paris

CH Henri Laborit, Poitiers

Chu Toulouse Hopital Purpan, Toulouse

CHU de Tours, Tours